Outcomes and Future Directions of Per-Oral Endoscopic Pyloromyotomy: A View from France.

EndoFLIP Gastric POEM Gastroparesis Per-oral pyloromyotomy Refractory gastroparesis Severe gastroparesis

Journal

Gastrointestinal endoscopy clinics of North America
ISSN: 1558-1950
Titre abrégé: Gastrointest Endosc Clin N Am
Pays: United States
ID NLM: 9202792

Informations de publication

Date de publication:
Jan 2019
Historique:
entrez: 7 11 2018
pubmed: 7 11 2018
medline: 23 2 2019
Statut: ppublish

Résumé

Gastroparesis is a challenging functional gastroenterological disorder, the complex pathophysiology of which hampers development of therapeutic modalities. Per-oral pyloromyotomy (POP) is a promising endoscopic therapy with a short-term clinical success rate of greater than 80%. Interest in POP is increasing, particularly in France, a country in which there is considerable expertise in submucosal endoscopy and functional disorders. Long-term follow-up and pyloric function evaluation are needed to assess the efficacy of POP in gastroparetic patients.

Identifiants

pubmed: 30396523
pii: S1052-5157(18)30791-8
doi: 10.1016/j.giec.2018.08.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-149

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Jérémie Jacques (J)

Gastroenterology Department, Limoges University Hospital, 2 Avenue Martin Luther King, Rouen 87042, France. Electronic address: jeremiejacques@gmail.com.

Romain Legros (R)

Gastroenterology Department, Limoges University Hospital, 2 Avenue Martin Luther King, Rouen 87042, France.

Jacques Monteil (J)

Nuclear Medicine Department, Limoges University Hospital, 2 Avenue Martin Luther King, Limoges 87042, France.

Denis Sautereau (D)

Gastroenterology Department, Limoges University Hospital, 2 Avenue Martin Luther King, Rouen 87042, France.

Guillaume Gourcerol (G)

Gastroenterology Department, Rouen University Hospital, 1 rue de Germont, Rouen 76038, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH